Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Clin Endocrinol Metab ; 105(5)2020 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-32034419

RESUMEN

CONTEXT: The reproductive axis is controlled by a network of gonadotropin-releasing hormone (GnRH) neurons born in the primitive nose that migrate to the hypothalamus alongside axons of the olfactory system. The observation that congenital anosmia (inability to smell) is often associated with GnRH deficiency in humans led to the prevailing view that GnRH neurons depend on olfactory structures to reach the brain, but this hypothesis has not been confirmed. OBJECTIVE: The objective of this work is to determine the potential for normal reproductive function in the setting of completely absent internal and external olfactory structures. METHODS: We conducted comprehensive phenotyping studies in 11 patients with congenital arhinia. These studies were augmented by review of medical records and study questionnaires in another 40 international patients. RESULTS: All male patients demonstrated clinical and/or biochemical signs of GnRH deficiency, and the 5 men studied in person had no luteinizing hormone (LH) pulses, suggesting absent GnRH activity. The 6 women studied in person also had apulsatile LH profiles, yet 3 had spontaneous breast development and 2 women (studied from afar) had normal breast development and menstrual cycles, suggesting a fully intact reproductive axis. Administration of pulsatile GnRH to 2 GnRH-deficient patients revealed normal pituitary responsiveness but gonadal failure in the male patient. CONCLUSIONS: Patients with arhinia teach us that the GnRH neuron, a key gatekeeper of the reproductive axis, is associated with but may not depend on olfactory structures for normal migration and function, and more broadly, illustrate the power of extreme human phenotypes in answering fundamental questions about human embryology.


Asunto(s)
Hormona Liberadora de Gonadotropina/metabolismo , Neuronas/fisiología , Nariz/anomalías , Trastornos del Olfato/congénito , Anomalías Múltiples/genética , Anomalías Múltiples/metabolismo , Anomalías Múltiples/patología , Anomalías Múltiples/fisiopatología , Adolescente , Adulto , Anciano , Niño , Preescolar , Estudios de Cohortes , Femenino , Hormona Folículo Estimulante/sangre , Hormona Liberadora de Gonadotropina/deficiencia , Gónadas/anomalías , Gónadas/patología , Humanos , Hipogonadismo/genética , Hipogonadismo/metabolismo , Hipogonadismo/patología , Hipogonadismo/fisiopatología , Lactante , Hormona Luteinizante/sangre , Masculino , Persona de Mediana Edad , Neurogénesis/fisiología , Neuronas/metabolismo , Trastornos del Olfato/genética , Trastornos del Olfato/metabolismo , Trastornos del Olfato/fisiopatología , Vías Olfatorias/metabolismo , Vías Olfatorias/patología , Tamaño de los Órganos , Adulto Joven
2.
Rev Esp Quimioter ; 26 Suppl 1: 1-84, 2013 01.
Artículo en Español | MEDLINE | ID: mdl-23824510

Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus , Acetamidas/efectos adversos , Acetamidas/farmacocinética , Acetamidas/farmacología , Acetamidas/uso terapéutico , Aminoglicósidos/efectos adversos , Aminoglicósidos/farmacocinética , Aminoglicósidos/farmacología , Aminoglicósidos/uso terapéutico , Animales , Antibacterianos/efectos adversos , Antibacterianos/farmacocinética , Antibacterianos/farmacología , Clindamicina/efectos adversos , Clindamicina/farmacocinética , Clindamicina/farmacología , Clindamicina/uso terapéutico , Daptomicina/efectos adversos , Daptomicina/farmacocinética , Daptomicina/farmacología , Daptomicina/uso terapéutico , Modelos Animales de Enfermedad , Fluoroquinolonas/efectos adversos , Fluoroquinolonas/farmacocinética , Fluoroquinolonas/farmacología , Fluoroquinolonas/uso terapéutico , Fosfomicina/efectos adversos , Fosfomicina/farmacocinética , Fosfomicina/farmacología , Fosfomicina/uso terapéutico , Guías como Asunto , Humanos , Linezolid , Pruebas de Sensibilidad Microbiana , Oxazolidinonas/efectos adversos , Oxazolidinonas/farmacocinética , Oxazolidinonas/farmacología , Oxazolidinonas/uso terapéutico , Rifampin/efectos adversos , Rifampin/farmacocinética , Rifampin/farmacología , Rifampin/uso terapéutico , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/efectos de los fármacos , Teicoplanina/efectos adversos , Teicoplanina/farmacocinética , Teicoplanina/farmacología , Teicoplanina/uso terapéutico , Tetraciclinas/efectos adversos , Tetraciclinas/farmacocinética , Tetraciclinas/farmacología
3.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 23(supl.5): 19-23, dic. 2005. tab, graf
Artículo en Español | IBECS | ID: ibc-174709

RESUMEN

La infección en el huésped deprimido supone una situación clínica de gravedad por su alta morbimortalidad, y es una de las complicaciones más frecuentes del paciente con cáncer. En los pacientes tratados con quimioterapia, el riesgo de infección depende fundamentalmente de la duración y la intensidad de la neutropenia. Es fundamental evaluar cuáles son los patógenos involucrados con mayor probabilidad para iniciar el tratamiento a priori más adecuado, así como la situación clínica general del paciente, que nos obligará a realizar un tratamiento más o menos agresivo desde el inicio, teniendo en cuenta que es posible el manejo domiciliario en el grupo de pacientes considerado de "bajo riesgo" de presentar complicaciones. Podremos conocer estas cuestiones evaluando los antecedentes y la historia clínica del paciente, mediante la exploración física y a partir de los datos del laboratorio y las exploraciones radiológicas. El inicio precoz de la antibioterapia de amplio espectro adaptada al riesgo del paciente es crucial


Infection in immunocompromised hosts represents a serious clinical situation due the high morbidity and mortality it produces and is one of the most frequent complications in patients with cancer. In patients treated with chemotherapy the risk of infection mainly depends on the duration and intensity of neutropenia. It is essential to evaluate which pathogens are involved so that the most appropriate treatment can be selected a priori, as well as to determine the patient's general clinical status so that more or less aggressive treatment can be provided from the beginning, bearing in mind that "low risk" patients can be managed in the home. These questions can be determined by evaluating the patient's clinical history, physical examination, laboratory investigations, and radiological tests. Prompt initiation of broad-spectrum antibiotic therapy adapted to the the patient's risk is crucial


Asunto(s)
Humanos , Neutropenia Febril Inducida por Quimioterapia/tratamiento farmacológico , Factores de Riesgo , Neoplasias/complicaciones , Neoplasias/inmunología , Huésped Inmunocomprometido , Antibacterianos/administración & dosificación , Gravedad del Paciente , Medición de Riesgo , Modelos de Riesgos Proporcionales
4.
Enferm Infecc Microbiol Clin ; 23 Suppl 5: 19-23, 2005 Dec.
Artículo en Español | MEDLINE | ID: mdl-16857152

RESUMEN

Infection in immunocompromised hosts represents a serious clinical situation due the high morbidity and mortality it produces and is one of the most frequent complications in patients with cancer. In patients treated with chemotherapy the risk of infection mainly depends on the duration and intensity of neutropenia. It is essential to evaluate which pathogens are involved so that the most appropriate treatment can be selected a priori, as well as to determine the patient's general clinical status so that more or less aggressive treatment can be provided from the beginning, bearing in mind that "low risk" patients can be managed in the home. These questions can be determined by evaluating the patient's clinical history, physical examination, laboratory investigations, and radiological tests. Prompt initiation of broad-spectrum antibiotic therapy adapted to the the patient's risk is crucial.


Asunto(s)
Neutropenia , Infecciones Oportunistas/prevención & control , Algoritmos , Fiebre , Humanos , Neoplasias/inmunología , Neutropenia/microbiología , Neutropenia/terapia , Medición de Riesgo
5.
Hum Mol Genet ; 13(11): 1171-81, 2004 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-15056605

RESUMEN

FOXL2 mutations cause gonadal dysgenesis or premature ovarian failure (POF) in women, as well as eyelid/forehead dysmorphology in both sexes (the 'blepharophimosis-ptosis-epicanthus inversus syndrome', BPES). Here we report that mice lacking Foxl2 recapitulate relevant features of human BPES: males and females are small and show distinctive craniofacial morphology with upper eyelids absent. Furthermore, in mice as in humans, sterility is confined to females. Features of Foxl2 null animals point toward a new mechanism of POF, with all major somatic cell lineages failing to develop around growing oocytes from the time of primordial follicle formation. Foxl2 disruption thus provides a model for histogenesis and reproductive competence of the ovary.


Asunto(s)
Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/fisiología , Ovario/patología , Insuficiencia Ovárica Primaria/etiología , Factores de Transcripción/genética , Factores de Transcripción/fisiología , Animales , Blefarofimosis/etiología , Blefarofimosis/genética , Modelos Animales de Enfermedad , Embrión de Mamíferos/patología , Párpados/anomalías , Femenino , Proteína Forkhead Box L2 , Factores de Transcripción Forkhead , Eliminación de Gen , Inmunoquímica , Antígeno Ki-67/inmunología , Masculino , Ratones , Ratones Noqueados , Ovario/embriología , Ovario/crecimiento & desarrollo , Insuficiencia Ovárica Primaria/genética , Insuficiencia Ovárica Primaria/patología , Síndrome
6.
Ann N Y Acad Sci ; 1034: 117-31, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15731305

RESUMEN

We review age-related changes in the ovary and their effect on female fertility, with particular emphasis on follicle formation, follicle dynamics, and oocyte quality. The evidence indicates that the developmental processes leading to follicle formation set the rules determining follicle quiescence and growth. This regulatory system is maintained until menopause and is directly affected in at least some models of premature ovarian failure (POF), most strikingly in the Foxl2 mouse knockout, a model of human POF with monogenic etiology (blepharophimosis/ptosis/epicanthus inversus syndrome). Several lines of evidence indicate that if the ovarian germ cell lineage maintains regenerative potential, as recently suggested in the mouse, a role in follicle dynamics for germ stem cells, if any, is likely indirect or secondary. In addition, age-related variations in oocyte quality in animal models suggest that reproductive competence is acquired progressively and might depend on parallel growth and differentiation of follicle cells and stroma. Genomewide analyses of the mouse oocyte transcriptome have begun to be used to systematically investigate the mechanisms of reproductive competence that are altered with aging. Investigative and therapeutic strategies can benefit from considering the role of continuous interactions between follicle cells and oocytes from the beginning of histogenesis to full maturation.


Asunto(s)
Envejecimiento/fisiología , Oocitos/fisiología , Ovario/fisiología , Reproducción/fisiología , Animales , Femenino , Humanos , Oocitos/citología , Ovario/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA